---
pmcid: PMC8190771
image_filename: ol-22-02-12837-g04.jpg
figure_link: /pmc/articles/PMC8190771/figure/f5-ol-0-0-12837/
number: Figure 5
figure_title: ''
caption: Enrichment plots from the GSEA database. GSEA showed that the (A) ‘TGF-β
  signaling pathway’, (B) the ‘cell cycle’, (C) ‘ubiquitin-mediated proteolysis’,
  (D) the ‘p53 signaling pathway’, (E) the ‘Wnt signaling pathway’ and (F) other pathways
  were differentially enriched in OLA1-related endometrial cancer. (G) Suppressing
  OLA1 expression decreased the expression of TGF-β maker genes (SMAD3 and SMAD4).
  (H) Knockdown of OLA1 suppressed expression of GSK3β, phosporylated-GSK3β and β-catenin.
  ****P<0.0001 compared with siNC. GSEA, Gene Set Enrichment Analysis; OLA1, Obg-like
  ATPase 1; p-, phosphorylated-; FDR, false discovery rate.
article_title: OLA1 is a potential prognostic molecular biomarker for endometrial
  cancer and promotes tumor progression.
citation: Yanqi Dong, et al. Oncol Lett. 2021 Aug;22(2):576.

doi: 10.3892/ol.2021.12837
journal_title: Oncology Letters
journal_nlm_ta: Oncol Lett
publisher_name: D.A. Spandidos

keywords:
- endometrial cancer
- the cancer genome atlas
- Obg-like ATPase 1
- prognosis
- signaling pathway
- gene set enrichment analysis

---
